Financial Year |
March 31 2023 |
Monetary Funds |
570,243,293.08 |
Held-for-trading Financial Assets |
43,635,319.17 |
Notes Receivable |
4,679,278.75 |
Accounts Receivable |
639,118,920.78 |
Advances to Suppliers |
95,212,572.22 |
Other Receivables |
6,183,435.29 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
548,789,504.42 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
25,900,965.46 |
Other Current Assets |
76,890,972.27 |
Total Current Assets |
2,088,433,491.44 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
24,694,413.29 |
Fixed Assetes |
358,563,037.21 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
83,815,609.19 |
R&D expenses |
-- |
Goodwill |
317,417,375.03 |
Long-Term Deferred and Prepaid Expenses |
1,397,006.96 |
Deferred Income Tax Assets |
8,117,915.84 |
Other Non-Current Assets |
8,604,923.12 |
Sub-Total of Non-Current Assets |
806,753,281.41 |
Total Assets |
2,895,186,772.85 |
Short-Term Loans |
2,800,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
23,278,466.47 |
Accounts Payable |
463,385,830.82 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
48,666,834.71 |
Taxes Payable |
96,178,565.04 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
55,036,497.06 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
457,533.37 |
Other Current Liabilities |
31,619,357.62 |
Sub-Total of Current Liabilities |
1,222,209,302.44 |
Long-term Loans |
8,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,020,809.15 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
14,149,150.34 |
Total Liabilities |
1,236,358,452.78 |
Paid-In Capital(Or Share Stock) |
1,421,506,508.00 |
Capital Surplus |
1,898,525,926.74 |
Surplus Reserve |
12,957,394.02 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-1,541,943,331.60 |
Minority Stockholder's Interest |
838,433.71 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,657,989,886.36 |
Owner's Equity(Stockholder's Equity) |
1,658,828,320.07 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,895,186,772.85 |